https://www.ediblerank.com Cannabis edibles as medicine, not recreation. Rankings, condition pages, dosing guides, science and regulatory coverage. en-us Sat, 14 Nov 2026 12:00:00 GMT https://www.ediblerank.com/news/hemp-ban-november-12-what-changed https://www.ediblerank.com/news/hemp-ban-november-12-what-changed Thu, 12 Nov 2026 12:00:00 GMT news November 12, 2026 took federal hemp status from one narrow group: cannabinoids the cannabis plant cannot make. Lab-converted delta-8, hemp delta-9 gummies and THCA keep theirs until December 11. What went today, what did not, and the three states that moved on their own clocks. https://www.ediblerank.com/news/hemp-ban-30-days-out-2026 https://www.ediblerank.com/news/hemp-ban-30-days-out-2026 Tue, 10 Nov 2026 12:00:00 GMT news Two federal hemp dates land four weeks apart, and most shoppers are watching the wrong one. Thursday's November 12 tranche reaches only cannabinoids the plant cannot make. December 11 brings total THC, the 0.4 mg per container cap and the end of lab-converted delta-8. Plan around December 11. https://www.ediblerank.com/news/michigan-naked-hippie-gummies-recall https://www.ediblerank.com/news/michigan-naked-hippie-gummies-recall Mon, 09 Nov 2026 12:00:00 GMT news On November 5 Michigan's Cannabis Regulatory Agency announced a voluntary recall of Naked Hippie Lucky Berry gummies made by The Gummie Joint over the past year. The notice says what to throw out and where it was sold. It does not say why a 5 mg gummy kept producing complaints. https://www.ediblerank.com/best/cbd-gummies https://www.ediblerank.com/best/cbd-gummies Sat, 07 Nov 2026 12:00:00 GMT best On December 11, 2026 a hemp gummy with more than 0.4mg of total THC in the container stops being hemp, and a full-spectrum CBD gummy carries ninety times that. Six isolate and THC-free gummies verified against their own certificates of analysis on November 7, 2026, ranked by total THC per jar, label accuracy, CBD per piece and price per milligram, with the honest arithmetic on what a 25mg gummy can do against the 300mg anxiety trials. https://www.ediblerank.com/guides/cbd-drug-interactions https://www.ediblerank.com/guides/cbd-drug-interactions Sat, 07 Nov 2026 12:00:00 GMT guides Every CBD interaction page lists every liver enzyme and every drug class, which is the same as no information. The label-grade story is one enzyme with a measured effect (CYP2C19), one drug with a patient-level case file (warfarin), three interactions measured in trials (clobazam, valproate and tacrolimus), and a dose gap of ten to seventy-five times between a gummy and the doses anyone measured. This page is the map, and it says what has been studied at a gummy dose: until 2026, nothing. https://www.ediblerank.com/guides/edibles-and-benzodiazepines https://www.ediblerank.com/guides/edibles-and-benzodiazepines Sat, 07 Nov 2026 12:00:00 GMT guides Two CNS depressants add up, which every benzodiazepine label already says. The one interaction with blood levels behind it is CBD roughly tripling clobazam's active metabolite, measured at 1,500mg of CBD a day. And the question people actually type, whether a gummy can replace the pill, comes down to two studies that disagree, and the controlled one found no change in benzodiazepine use. https://www.ediblerank.com/guides/edibles-and-blood-thinners https://www.ediblerank.com/guides/edibles-and-blood-thinners Sat, 07 Nov 2026 12:00:00 GMT guides Warfarin is the one cannabis interaction with published, patient-level evidence, and the cannabinoid with the cleanest trail through it is CBD, at Epidiolex doses no gummy reaches. THC cases exist with unknown doses. For apixaban, rivaroxaban and clopidogrel the record is label inference, and this page says which inference the Epidiolex label supports. https://www.ediblerank.com/guides/edibles-and-immunosuppressants https://www.ediblerank.com/guides/edibles-and-immunosuppressants Sat, 07 Nov 2026 12:00:00 GMT guides Transplant drugs are where a dose gap stops being comfort. A phase 1 trial tripled tacrolimus exposure at about 33 gummies' worth of CBD a day, everolimus rose 2.5-fold, and the Prograf, Zortress and sirolimus labels now carry cannabidiol sections of their own. Nobody has measured a nightly gummy, so one blood test settles the level question, and the transplant clinic can order it. https://www.ediblerank.com/guides/edibles-and-opioids https://www.ediblerank.com/guides/edibles-and-opioids Sat, 07 Nov 2026 12:00:00 GMT guides Two questions sit under edibles and opioids, and the answers run opposite ways. Safety reads scarier than it measures in healthy volunteers and is unmeasured in the frail patients the boxed warning was written for. The opioid-sparing claim reads better than it measures: lab results and dispensary surveys on one side, trials and a four-year cohort on the other. https://www.ediblerank.com/guides/edibles-and-seizure-medications https://www.ediblerank.com/guides/edibles-and-seizure-medications Sat, 07 Nov 2026 12:00:00 GMT guides Seizure drugs have the fullest interaction record any cannabinoid has, because CBD is itself a labeled antiepileptic. Clobazam's active metabolite roughly triples, valproate raises the liver risk, and most of the others barely move. Those numbers came from 10 to 20 mg/kg a day, 28 to 56 times a 25mg gummy for a 70kg adult, and a PubMed search finds no human study of what THC does to seizure threshold. https://www.ediblerank.com/guides/edibles-before-surgery https://www.ediblerank.com/guides/edibles-before-surgery Sat, 07 Nov 2026 12:00:00 GMT guides The only clinicians with written rules for cannabis and surgery are anesthesiologists, and their 2023 guideline is calmer than the forum folklore: ask every patient, postpone only for intoxication or a fresh smoke, no waiting period for edibles. The edible-specific problems are the fasting clock, an effect window that runs 4 to 8 hours, and a recovery room where regular users need more propofol and report more pain. https://www.ediblerank.com/guides/edibles-during-pregnancy-and-breastfeeding https://www.ediblerank.com/guides/edibles-during-pregnancy-and-breastfeeding Sat, 07 Nov 2026 12:00:00 GMT guides This is the one question where following the evidence and following ACOG, the AAP and the FDA land in the same place. The cohort data are observational and confounded, the breast-milk measurements are uncomfortable, no trial has tested a cannabinoid for morning sickness, and nobody has published what a gummy does to fetal exposure. https://www.ediblerank.com/guides/edibles-for-older-adults https://www.ediblerank.com/guides/edibles-for-older-adults Sat, 07 Nov 2026 12:00:00 GMT guides Older adults are one of the fastest-growing groups of cannabis users and one of the least studied. One of the most reassuring low-dose studies screened out frequent fallers and people on opioids, and nobody has counted falls in older edible users. The realistic risks are a fall, a stacked sedative, a blood-pressure drop on standing and confusion read as dementia. https://www.ediblerank.com/legal/hemp-ban-lawsuits https://www.ediblerank.com/legal/hemp-ban-lawsuits Sat, 07 Nov 2026 12:00:00 GMT legal A running tracker of the lawsuits around the federal hemp ban and the state bans beside it: Texas, Ohio, Missouri, Illinois, Connecticut and Hawaii. Who is suing whom, the last action with its date, the next date if one exists, and what each outcome means for a buyer. https://www.ediblerank.com/legal/marijuana-rescheduling https://www.ediblerank.com/legal/marijuana-rescheduling Sat, 07 Nov 2026 12:00:00 GMT legal The owner page for marijuana rescheduling: the April 28 order, the DEA hearing, the stay, the D.C. Circuit challenge, the first federal dispensary registrations, and what Schedule III would and would not change for someone buying a dispensary edible. https://www.ediblerank.com/science/11-hydroxy-thc https://www.ediblerank.com/science/11-hydroxy-thc Sat, 07 Nov 2026 12:00:00 GMT science 11-hydroxy-THC is real, the liver makes it in quantity only from swallowed THC, and after an edible it circulates at about the same level as THC itself. That explains part of the heavier, longer edible high. The rest is a delay problem and a bioavailability problem the label never mentions: 10 to 20 percent of an oral dose reaches the blood, and one liver enzyme variant triples it. https://www.ediblerank.com/science/cbg https://www.ediblerank.com/science/cbg Sat, 07 Nov 2026 12:00:00 GMT science CBG is the non-intoxicating cannabinoid formed from CBGA, the plant's precursor, and it sells on a focus-and-calm story. In people: a 34-adult trial at 20mg with a small anxiety signal and about one extra word recalled, a 12-adult dose study with few effects, a null veterans sleep trial, and an 80mg attention trial that finished in July and has posted no results. https://www.ediblerank.com/science/edible-tolerance https://www.ediblerank.com/science/edible-tolerance Sat, 07 Nov 2026 12:00:00 GMT science CB1 tolerance is real and measurable, and every PET scan behind it recruited chronic or dependent users rather than nightly gummy patients. Most of the oral data is capsules at 40 to 240mg a day in people who already smoke. Here is what that evidence supports, what it contradicts, and what nobody has measured. https://www.ediblerank.com/science/endocannabinoid-system https://www.ediblerank.com/science/endocannabinoid-system Sat, 07 Nov 2026 12:00:00 GMT science The endocannabinoid system is real, mapped in detail since 1992, and the most decorative word in cannabis marketing. For someone who takes edibles it explains four things: why THC is intoxicating and CBD is not, why a dose stops working and how fast that reverses, why a 1:1 gummy behaves differently from THC alone, and why 'balancing your ECS' on a jar means nothing. The rest is a wellness story told in textbook vocabulary. https://www.ediblerank.com/science/terpenes-in-edibles https://www.ediblerank.com/science/terpenes-in-edibles Sat, 07 Nov 2026 12:00:00 GMT science Terpenes are real molecules with real pharmacology, and almost none of it has been shown in a person who swallowed a gummy. Published lab certificates put two New York gummies at 2.2 and 2.9mg of total terpenes, while the human trials that can pin an effect on one terpene used 15mg or more. Live resin buys a flavor and a story. https://www.ediblerank.com/news/missouri-hemp-ban-lawsuit-dismissed https://www.ediblerank.com/news/missouri-hemp-ban-lawsuit-dismissed Thu, 05 Nov 2026 12:00:00 GMT news A federal judge dismissed the hemp industry's challenge to HB 2641 on November 4, eight days before the law takes effect, and the Attorney General announced four consumer-fraud suits the same afternoon. Here is what closes in Missouri on November 12, what stays on the shelf until December 11, and what a Missouri buyer does about it. https://www.ediblerank.com/best/fast-acting-edibles https://www.ediblerank.com/best/fast-acting-edibles Mon, 02 Nov 2026 12:00:00 GMT best Fast-acting is real, and it is about forty minutes, not ten. In the one trial that drew blood after retail fast-acting gummies, every product peaked between 36 and 91 minutes and the fast-acting Wana did not beat the regular Wana. Eight products ranked by published evidence, dose grid, channel and price per 5mg of THC on named menus read November 2, 2026, plus the state label texts that argue with the box. https://www.ediblerank.com/dispensaries/new-york/new-york-city https://www.ediblerank.com/dispensaries/new-york/new-york-city Mon, 02 Nov 2026 12:00:00 GMT dispensaries A 100mg Wyld tin is $22.50 to $31 at licensed New York City counters this week, against $14.95 in Denver. The 309 legal stores by borough from the state's own licence file, how to check a licence before you walk in, what the register adds and why the price is high before it, the medical arithmetic, and where to go first. https://www.ediblerank.com/types/papa-and-barkley-vs-wyld https://www.ediblerank.com/types/papa-and-barkley-vs-wyld Mon, 02 Nov 2026 12:00:00 GMT types A Papa & Barkley gummy pack costs $20 to $30 on the four Los Angeles-area menus we read on November 2, 2026, where a Wyld tin costs $13 to $21. What the extra buys a pain or sleep patient, what the one human trial of whole plant against pure THC found, and why Wyld's own hemp blog settles the terpene argument the two brands are having. https://www.ediblerank.com/guides/edibles-and-antidepressants https://www.ediblerank.com/guides/edibles-and-antidepressants Fri, 30 Oct 2026 12:00:00 GMT guides The CBD and sertraline interaction everyone warns about was measured at hundreds of milligrams a day, and a gummy carries 25. The interaction with a label behind it is sedation, when THC lands on top of mirtazapine or trazodone at bedtime. And the question underneath all of it is what regular THC does to the depression itself. https://www.ediblerank.com/conditions/alcohol-use-disorder https://www.ediblerank.com/conditions/alcohol-use-disorder Tue, 27 Oct 2026 12:00:00 GMT conditions No guideline lists cannabis for alcohol withdrawal, the substitution evidence is mostly surveys of people who already liked cannabis, and the largest CBD trial in alcohol use disorder found nothing placebo did not. What was studied, what was found, and the two medications with the trial record. https://www.ediblerank.com/conditions/als https://www.ediblerank.com/conditions/als Tue, 27 Oct 2026 12:00:00 GMT conditions Cannabis gets asked to do two jobs in ALS. For spasticity, one six-week trial of a THC and CBD spray beat placebo and the European guideline now lists cannabinoids. For cramps, THC did no better than placebo. For slowing the disease, the evidence is mice, and the one human trial built to test it never published. https://www.ediblerank.com/conditions/alzheimers-agitation https://www.ediblerank.com/conditions/alzheimers-agitation Tue, 27 Oct 2026 12:00:00 GMT conditions Two prescription cannabinoids, nabilone and dronabinol, have beaten placebo on at least one agitation scale in small, short trials of people with Alzheimer's dementia, and a low-dose THC trial found nothing. Sedation is the side effect that keeps showing up. A dispensary gummy appears in none of the trials, and the question belongs with the prescriber and care team. https://www.ediblerank.com/conditions/appetite-loss-older-adults https://www.ediblerank.com/conditions/appetite-loss-older-adults Tue, 27 Oct 2026 12:00:00 GMT conditions The best-designed trial of cannabis for poor appetite in people over 65 found they ate 10 calories more than on placebo. Dronabinol's label asks for a lower start and fall precautions in elderly patients, and cannabis emergency visits in older adults are climbing. An edible is a narrow, supervised option after the cause of the appetite loss has been looked for. https://www.ediblerank.com/conditions/autism-adults https://www.ediblerank.com/conditions/autism-adults Tue, 27 Oct 2026 12:00:00 GMT conditions Almost every controlled cannabinoid trial in autism enrolled children with severe behaviour problems, and most missed their main targets. What the trials gave, what autistic adults report, and what the prescriber needs to know. https://www.ediblerank.com/conditions/cannabis-use-disorder https://www.ediblerank.com/conditions/cannabis-use-disorder Tue, 27 Oct 2026 12:00:00 GMT conditions In the one randomized trial of medical cannabis cards, people handed a card developed cannabis use disorder at twice the rate of those told to wait, with no gain on pain, anxiety or depression. What the diagnosis means, how withdrawal runs, what the CBD trial found, and why no medication is approved. https://www.ediblerank.com/conditions/end-of-life-symptoms https://www.ediblerank.com/conditions/end-of-life-symptoms Tue, 27 Oct 2026 12:00:00 GMT conditions In hospice, the long-term risks that dominate other cannabis debates matter least and comfort matters most. The trials in advanced illness mostly did no better than placebo, the sedation adds to the opioids and benzodiazepines already on board, and in the last week the person often cannot swallow a gummy at all. https://www.ediblerank.com/conditions/epilepsy-seizures https://www.ediblerank.com/conditions/epilepsy-seizures Tue, 27 Oct 2026 12:00:00 GMT conditions Purified CBD has four positive placebo-controlled trials in three severe childhood epilepsies, and it is a prescription oral solution dosed by body weight. Matching the trial dose with retail CBD gummies takes 28 to 56 of them a day, and independent testing found CBD labels accurate less than a third of the time. https://www.ediblerank.com/conditions/glaucoma https://www.ediblerank.com/conditions/glaucoma Tue, 27 Oct 2026 12:00:00 GMT conditions THC lowers eye pressure for three to four hours, and glaucoma runs all 24. Every major eye society advises against cannabis for glaucoma, and an edible's slow, uneven onset makes the arithmetic worse than the joint it replaced. https://www.ediblerank.com/conditions/hiv-wasting https://www.ediblerank.com/conditions/hiv-wasting Tue, 27 Oct 2026 12:00:00 GMT conditions HIV wasting is the one condition where a cannabinoid has carried an FDA label since 1992. The trials behind it moved appetite more than weight, the weight that did come was mostly fat, and in 2026 the more useful cannabis question for someone on antiretrovirals is what the booster in their regimen does to THC and CBD. https://www.ediblerank.com/conditions/huntingtons-disease https://www.ediblerank.com/conditions/huntingtons-disease Tue, 27 Oct 2026 12:00:00 GMT conditions Three small controlled trials have tested cannabinoids in Huntington's disease, each with a different molecule. CBD did no better than placebo, a THC and CBD spray did no better than placebo, and nabilone gave a small chorea signal in a five-week pilot. None changed the disease, and THC's mood effects land in a disease with high suicide risk. https://www.ediblerank.com/conditions/interstitial-cystitis https://www.ediblerank.com/conditions/interstitial-cystitis Tue, 27 Oct 2026 12:00:00 GMT conditions No one has finished a cannabis trial in interstitial cystitis, and the AUA guideline never mentions it. The bladder evidence comes from MS, the pain case is borrowed, and the ingredient panel matters more than the ratio, because most gummies are acidified fruit candy and the drinks are sparkling citrus. https://www.ediblerank.com/conditions/ocd https://www.ediblerank.com/conditions/ocd Tue, 27 Oct 2026 12:00:00 GMT conditions The only placebo-controlled test of cannabis in OCD found the real thing did no better than a placebo cigarette on obsessions and compulsions. App users report big short-term relief, and that relief fades for intrusions. What the evidence says about THC, CBD and the treatments that work. https://www.ediblerank.com/conditions/opioid-use-disorder https://www.ediblerank.com/conditions/opioid-use-disorder Tue, 27 Oct 2026 12:00:00 GMT conditions The study that made cannabis an answer to the opioid crisis reversed when the data ran seven more years. Prescription THC eased withdrawal modestly in a hospital, CBD lowered craving in a lab, and methadone and buprenorphine are the treatments tied to fewer overdose deaths. https://www.ediblerank.com/conditions/rheumatoid-arthritis https://www.ediblerank.com/conditions/rheumatoid-arthritis Tue, 27 Oct 2026 12:00:00 GMT conditions Rheumatoid arthritis is autoimmune, so how a joint feels and what the disease is doing to it are two separate questions. Cannabis has one small trial behind it for the first and nothing for the second, and anyone on methotrexate or leflunomide already has a liver-test schedule that their rheumatologist reads. https://www.ediblerank.com/conditions/sickle-cell-pain https://www.ediblerank.com/conditions/sickle-cell-pain Tue, 27 Oct 2026 12:00:00 GMT conditions The only randomized trial of cannabis in sickle cell disease missed its pain endpoint and moved one mood score. Clinic studies split on hospital visits, a pain crisis needs treatment within the hour, and an edible's onset rules it out for anything but the daily background pain. https://www.ediblerank.com/conditions/sleep-apnea https://www.ediblerank.com/conditions/sleep-apnea Tue, 27 Oct 2026 12:00:00 GMT conditions Prescription dronabinol lowered apnea counts in two small trials and left blood oxygen where it was. The American Academy of Sleep Medicine says cannabis should not be used for obstructive sleep apnea, dispensary edibles were never tested, and CPAP and one FDA-approved drug carry the evidence. https://www.ediblerank.com/conditions/spinal-cord-injury-spasticity https://www.ediblerank.com/conditions/spinal-cord-injury-spasticity Tue, 27 Oct 2026 12:00:00 GMT conditions Two small trials built around spinal cord injury spasticity randomized 25 people between them, and the largest oral capsule trial found THC no better than placebo. An edible is a borrowed-evidence add-on at best, and the injury adds two hazards the MS trials never had to weigh: blood pressure that already drops on sitting up, and transfers that lean on the stiffness. https://www.ediblerank.com/conditions/tension-headache https://www.ediblerank.com/conditions/tension-headache Tue, 27 Oct 2026 12:00:00 GMT conditions Tension-type headache affects almost two billion people and has never had a published cannabis trial. A gummy that takes 30 minutes to 2 hours to start meets a headache that ibuprofen handles, and for anyone treating headaches most days, the cannabis risk worth knowing is rebound headache. https://www.ediblerank.com/conditions/tmj-pain https://www.ediblerank.com/conditions/tmj-pain Tue, 27 Oct 2026 12:00:00 GMT conditions The TMJ cannabis result everyone cites came from a CBD ointment rubbed on the jaw muscle. Swallowed CBD at 20mg a day did no better than hemp seed oil, cannabis users report more clenching and grinding, and the gummy itself is a chewing problem on a sore jaw. https://www.ediblerank.com/conditions/ulcerative-colitis https://www.ediblerank.com/conditions/ulcerative-colitis Tue, 27 Oct 2026 12:00:00 GMT conditions The gummy's sugar alcohol and the chocolate's fat are smaller problems than people fear. The bigger one is that THC makes colitis feel better in trials while the colon heals no faster, and cannabis users with UC turn up in the emergency department more than twice as often. https://www.ediblerank.com/news/dea-judge-denies-rescheduling-reopen https://www.ediblerank.com/news/dea-judge-denies-rescheduling-reopen Tue, 27 Oct 2026 12:00:00 GMT news On October 22 the DEA's chief judge refused opponents a new round of testimony, let the GAO report into the record, and gave every party ten pages to argue about it. The stay ends November 5. Here is what that does and does not change for edibles. https://www.ediblerank.com/conditions/adhd https://www.ediblerank.com/conditions/adhd Thu, 22 Oct 2026 12:00:00 GMT conditions Adults with ADHD report cannabis calms restlessness. The one trial found a hint on hyperactivity and nothing on attention. What the evidence supports, and what it does not. https://www.ediblerank.com/science/cbn-vs-cbd-for-sleep https://www.ediblerank.com/science/cbn-vs-cbd-for-sleep Thu, 22 Oct 2026 12:00:00 GMT science Every positive CBN sleep trial used 20mg or more. The CBD sleep evidence at gummy doses is one uncontrolled chart review. And two industry-funded trials found the CBN-plus-CBD combination adds nothing. The trial literature on CBN versus CBD for sleep, with a trial-dose versus shelf-dose table. https://www.ediblerank.com/conditions/parkinsons-tremor https://www.ediblerank.com/conditions/parkinsons-tremor Wed, 21 Oct 2026 12:00:00 GMT conditions Patients report tremor relief in surveys and open-label studies, and the placebo-controlled trials mostly find no motor benefit. The one CBD signal is tremor driven by anxiety, while THC brings dizziness, low standing blood pressure and falls to a population already prone to all three.